Page last updated: 2024-08-21

clopenthixol and Parkinson Disease, Secondary

clopenthixol has been researched along with Parkinson Disease, Secondary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabriel, E; Karobath, M; Lenz, G	1
Gerlach, J; Hagert, U; Lublin, H; Meidahl, B; Mølbjerg, C; Pedersen, V; Rendtorff, C; Tolvanen, E	1
Balant, LP; Balant-Gorgia, AE; Eisele, R; Garrone, G; Gex-Fabry, M; Reith, B	1

Trials

1 trial(s) available for clopenthixol and Parkinson Disease, Secondary

Article	Year
Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1991, Volume: 1, Issue:4 Topics: Adult; Aged; Clopenthixol; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders	1991

Article

Year

Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1991, Volume: 1, Issue:4

Topics: Adult; Aged; Clopenthixol; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders

1991

Other Studies

2 other study(ies) available for clopenthixol and Parkinson Disease, Secondary

Article	Year
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis]. Der Nervenarzt, 1976, Volume: 47, Issue:1 Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine	1976
Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Pharmacopsychiatry, 1989, Volume: 22, Issue:6 Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Clopenthixol; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders; Thioxanthenes	1989

Article

Year

[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].

Der Nervenarzt, 1976, Volume: 47, Issue:1

Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine

1976

Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.

Pharmacopsychiatry, 1989, Volume: 22, Issue:6

Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Clopenthixol; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders; Thioxanthenes

1989